Zacks Investment Research
02 Apr 2026, 17:21 UTC · 25w ago
Verdict
Headline takes no side. We score GRDN +1.00 across three claims — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Guardian Pharmacy Services (GRDN) has been assigned a Zacks Rank #1 (Strong Buy) rating.
More positive than 79% of claims this week
Analysts have revised the full-year earnings consensus estimate for Guardian Pharmacy upward by 19.69% over the past month.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 66% of claims this week
Guardian Pharmacy's current quarter earnings estimate is $0.24 per share, a 14.3% increase over the previous year.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company has a Zacks Rank #1 (Strong Buy) with improving earnings estimates and positive price momentum.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+9.4%
Price agrees with the score
$41.16 vs $37.62 close before publication (Apr 1) · not market-adjusted
GRDN chart →